What is Imatrex?
Imatrex Inc. was historically a developer of advanced medical imaging and image-guided radiotherapy equipment. While the company has currently paused its operational activities, it continues to offer service for its existing Imatron EBCT Scanners within the U.S. Its target clientele comprised healthcare facilities and professionals engaged with medical imaging technologies. The company's legacy is rooted in its past contributions to innovation within the medical device sector.
How much funding has Imatrex raised?
Imatrex has raised a total of $1M across 2 funding rounds:
Debt
$350K
Debt
$648K
Debt (2020): $350K with participation from PPP
Debt (2021): $648K led by PPP
Key Investors in Imatrex
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Imatrex?
The substantial enterprise-level funding and recent strategic investment suggest a potential for operational revival or strategic restructuring for Imatrex. Given the company's current pause in operations and focus on servicing existing equipment, future capital deployment may be directed towards research and development for next-generation imaging technologies, strategic partnerships to re-enter the market, or potential acquisition by a larger entity in the healthcare technology space. The nature of the recent 'major strategic investment' implies a forward-looking approach by its backers, possibly aimed at leveraging Imatrex's established service infrastructure and brand recognition in the medical imaging field.
See full Imatrex company page
